Translational pharmacogenetics: pharmacogenetically driven clinical decision making
Author:
Stingl Julia Carolin
Reference116 articles.
1. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole;Andersson;Br. J. Clin. Pharmacol.,1998
2. Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer;Araki;Cancer Sci.,2006
3. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder;Bauer;World J. Biol. Psychiatry,2002
4. Influence of the CYP2D6∗4 polymorphism on dose, switching and discontinuation of antidepressants;Bijl;Br. J. Clin. Pharmacol.,2008
5. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine;Black;Ann. Intern. Med.,1998